Everhart Financial Group, Inc.
- SEC CIK
- 0001852858
- Latest filing
- Jul 8, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by Everhart Financial Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −459−100.0% | Sold out | Holders |
| Q1 2026 | 459 | $240.3K | <0.1% | −704−60.5% | Reduced | Holders |
| Q4 2025 | 1,163 | $677.3K | 0.1% | +704+153.4% | Added | Holders |
| Q3 2025 | 459 | $210.5K | <0.1% | −919−66.7% | Reduced | Holders |
| Q2 2025 | 1,378 | $417.0K | <0.1% | −250−15.4% | Reduced | Holders |
| Q1 2025 | 1,628 | $539.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,628 | $502.4K | 0.1% | −25−1.5% | Reduced | Holders |
| Q3 2024 | 1,653 | $350.8K | 0.1% | +250+17.8% | Added | Holders |
| Q2 2024 | 1,403 | $393.1K | 0.1% | +25+1.8% | Added | Holders |
| Q1 2024 | 1,378 | $368.0K | 0.1% | +235+20.6% | Added | Holders |
| Q4 2023 | 1,143 | $264.5K | 0.1% | +1,143 | New | Holders |